Revisiting the seed and soil in cancer metastasis

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 7, 2009, Pages 1452-1462

  Mendoza, Martin ^a   Khanna, Chand ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Metastasis; Microenvironment; Seed; Soil; Stress

Indexed keywords

BETA INTERFERON; CHEMOKINE; GAMMA INTERFERON; GROWTH FACTOR; HEAT SHOCK PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TIRAPAZAMINE;

CANCER CELL; CANCER STEM CELL; CELL INTERACTION; CENTRAL NERVOUS SYSTEM METASTASIS; GENE THERAPY; HOST CELL; HUMAN; HYPOXIA; INFLAMMATION; METASTASIS; MICROENVIRONMENT; NONHUMAN; NUTRITIONAL STATUS; PANCREAS ADENOCARCINOMA; PH; SHORT SURVEY; STRESS; TUMOR CELL; TUMOR GROWTH;

ANIMALS; CELL HYPOXIA; HEAT-SHOCK PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; INFLAMMATION; NEOPLASM METASTASIS; NEOPLASM SEEDING;

EID: 63249114825     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.01.015     Document Type: Short Survey

References (246)

1. Aeed P.A., Nakajima M., and Welch D.R. The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762NF mammary adenocarcinoma cells. Int J Cancer 42 (1988) 748-759
2. Al-Hajj M., Becker M.W., Wicha M., Weissman I., and Clarke M.F. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 14 (2004) 43-47
3. Ambs S., Hussain S.P., and Harris C.C. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 11 (1997) 443-448
4. Aplin A.E., Howe A.K., and Juliano R.L. Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol 11 (1999) 737-744
5. Arteaga C.L. EGF receptor mutations in lung cancer: from humans to mice and maybe back to humans. Cancer Cell 9 (2006) 421-423
6. Barnhart B.C., and Simon M.C. Metastasis and stem cell pathways. Cancer Metastasis Rev 26 (2007) 261-271
7. Bates R.C., Bellovin D.I., Brown C., Maynard E., Wu B., Kawakatsu H., et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 115 (2005) 339-347
8. Becknell B., and Caligiuri M.A. Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv Immunol 86 (2005) 209-239
9. Bellone G., Aste-Amezaga M., Trinchieri G., and Rodeck U. Regulation of NK cell functions by TGF-beta 1. J Immunol 155 (1995) 1066-1073
10. Belotti D., Calcagno C., Garofalo A., Caronia D., Riccardi E., Giavazzi R., et al. Vascular endothelial growth factor stimulates organ-specific host matrix metalloproteinase-9 expression and ovarian cancer invasion. Mol Cancer Res 6 (2008) 525-534
11. Bertotti A., Comoglio P.M., and Trusolino L. Beta4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesis. Cancer Res 65 (2005) 10674-10679
12. Bertotti A., Comoglio P.M., and Trusolino L. Beta4 integrin activates a Shp2-Src signaling pathway that sustains HGF-induced anchorage-independent growth. J Cell Biol 175 (2006) 993-1003
13. Bhowmick N.A., Neilson E.G., and Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 432 (2004) 332-337
14. Bierie B., and Moses H.L. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6 (2006) 506-520
15. Binder C., Binder L., Marx D., Schauer A., and Hiddemann W. Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues. Anticancer Res 17 (1997) 4299-4304
16. Birchmeier C., Birchmeier W., Gherardi E., and Vande Woude G.F. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4 (2003) 915-925
17. Blagosklonny M.V., Fojo T., Bhalla K.N., Kim J.S., Trepel J.B., Figg W.D., et al. The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy. Leukemia 15 (2001) 1537-1543
18. Boccaccio C., and Comoglio P.M. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 6 (2006) 637-645
19. Boire A., Covic L., Agarwal A., Jacques S., Sherifi S., and Kuliopulos A. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120 (2005) 303-313
20. Borsig L. The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther 8 (2008) 1247-1255
21. Brideau G., Makinen M.J., Elamaa H., Tu H., Nilsson G., Alitalo K., et al. Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res 67 (2007) 11528-11535
22. Brigati C., Noonan D.M., Albini A., and Benelli R. Tumors and inflammatory infiltrates: friends or foes?. Clin Exp Metastasis 19 (2002) 247-258
23. Brizel D.M., Scully S.P., Harrelson J.M., Layfield L.J., Bean J.M., Prosnitz L.R., et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56 (1996) 941-943
24. Brown L.F., Guidi A.J., Schnitt S.J., Van De Water L., Iruela-Arispe M.L., Yeo T.K., et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 5 (1999) 1041-1056
25. Brown N.S., and Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res 3 (2001) 323-327
26. Byzova T.V., Kim W., Midura R.J., and Plow E.F. Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. Exp Cell Res 254 (2000) 299-308
27. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., Hamner B., et al. A perivascular niche for brain tumor stem cells. Cancer Cell 11 (2007) 69-82
28. Cardones A.R., Murakami T., and Hwang S.T. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res 63 (2003) 6751-6757
29. Caruso R.A., Bellocco R., Pagano M., Bertoli G., Rigoli L., and Inferrera C. Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol 15 (2002) 831-837
30. Caswell P.T., and Norman J.C. Integrin trafficking and the control of cell migration. Traffic 7 (2006) 14-21
31. Chandler J.D., Williams E.D., Slavin J.L., Best J.D., and Rogers S. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma. Cancer 97 (2003) 2035-2042
32. Chen J.J., Lin Y.C., Yao P.L., Yuan A., Chen H.Y., Shun C.T., et al. Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol 23 (2005) 953-964
33. Cho R.W., Wang X., Diehn M., Shedden K., Chen G.Y., Sherlock G., et al. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 26 (2008) 364-371
34. Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452 (2008) 230-233
35. Ciampolillo A., De Tullio C., Perlino E., and Maiorano E. The IGF-I axis in thyroid carcinoma. Curr Pharm Des 13 (2007) 729-735
36. Condeelis J., and Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124 (2006) 263-266
37. Cook T., Wang Z., Alber S., Liu K., Watkins S.C., Vodovotz Y., et al. Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53. Cancer Res 64 (2004) 8015-8021
38. Cordon-Cardo C., O'Brien J.P., Casals D., Rittman-Grauer L., Biedler J.L., Melamed M.R., et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A 86 (1989) 695-698
39. Coussens L.M., Tinkle C.L., Hanahan D., and Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103 (2000) 481-490
40. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
41. Craighead P.S., Pearcey R., and Stuart G. A phase I/II evaluation of tirapazamine administered intravenously concurrent with cisplatin and radiotherapy in women with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 48 (2000) 791-795
42. Croker A.K., and Allan A.L. Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cell Mol Med 12 (2008) 374-390
43. Cunha G.R., Hayward S.W., Wang Y.Z., and Ricke W.A. Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107 (2003) 1-10
44. De Jaeger K., Kavanagh M.C., and Hill R.P. Relationship of hypoxia to metastatic ability in rodent tumours. Br J Cancer 84 (2001) 1280-1285
45. De Jaeger K., Merlo F.M., Kavanagh M.C., Fyles A.W., Hedley D., and Hill R.P. Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis. Int J Radiat Oncol Biol Phys 42 (1998) 717-721
46. Derynck R., Akhurst R.J., and Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29 (2001) 117-129
47. Deryugina E.I., and Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25 (2006) 9-34
48. Dickson R.B., and Deb T.B. EGF receptor in breast cancer chemoresistance. Adv Exp Med Biol 608 (2007) 113-118
49. Ding Y., Shimada Y., Maeda M., Kawabe A., Kaganoi J., Komoto I., et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res 9 (2003) 3406-3412
50. Dong D., Ni M., Li J., Xiong S., Ye W., Virrey J.J., et al. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res 68 (2008) 498-505
51. Dustin M.L., Rothlein R., Bhan A.K., Dinarello C.A., and Springer T.A. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137 (1986) 245-254
52. Dvorak H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315 (1986) 1650-1659
53. Eble J.A., and Haier J. Integrins in cancer treatment. Curr Cancer Drug Targets 6 (2006) 89-105
54. Enns A., Korb T., Schluter K., Gassmann P., Spiegel H.U., Senninger N., et al. Alphavbeta5-integrins mediate early steps of metastasis formation. Eur J Cancer 41 (2005) 1065-1072
55. Fang S., Jin X., Wang R., Li Y., Guo W., Wang N., et al. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis 26 (2005) 481-486
56. Fernandez-Salas E., Sagar M., Cheng C., Yuspa S.H., and Weinberg W.C. p53 and tumor necrosis factor alpha regulate the expression of a mitochondrial chloride channel protein. J Biol Chem 274 (1999) 36488-36497
57. Fernandez-Salas E., Suh K.S., Speransky V.V., Bowers W.L., Levy J.M., Adams T., et al. mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53. Mol Cell Biol 22 (2002) 3610-3620
58. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 4-25
59. Fidler I.J., and Kripke M.L. Metastasis results from preexisting variant cells within a malignant tumor. Science 197 (1977) 893-895
60. Forsberg K., Valyi-Nagy I., Heldin C.H., Herlyn M., and Westermark B. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci U S A 90 (1993) 393-397
61. Franchi A., Massi D., Santucci M., Masini E., Degl'Innocenti D.R., Magnelli L., et al. Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma. J Pathol 208 (2006) 439-445
62. Fu Y., and Lee A.S. Glucose regulated proteins in cancer progression, drug resistance and immunotherapy. Cancer Biol Ther 5 (2006) 741-744
63. Fu Y., Li J., and Lee A.S. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res 67 (2007) 3734-3740
64. Fukumura D., Xavier R., Sugiura T., Chen Y., Park E.C., Lu N., et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 94 (1998) 715-725
65. Galmozzi E., Facchetti F., and La Porta C.A. Cancer stem cells and therapeutic perspectives. Curr Med Chem 13 (2006) 603-607
66. Gatenby R.A., and Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 4 (2004) 891-899
67. Gillessen S., Naumov Y.N., Nieuwenhuis E.E., Exley M.A., Lee F.S., Mach N., et al. CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion. Proc Natl Acad Sci U S A 100 (2003) 8874-8879
68. Giraudo E., Inoue M., and Hanahan D. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 114 (2004) 623-633
69. Gorelik E., Wiltrout R.H., Brunda M.J., Holden H.T., and Herberman R.B. Augmentation of metastasis formation by thioglycollate-elicited macrophages. Int J Cancer 29 (1982) 575-581
70. Gorelik E., Wiltrout R.H., Copeland D., and Herberman R.B. Modulation of formation of tumor metastases by peritoneal macrophages elicited by various agents. Cancer Immunol Immunother 19 (1985) 35-42
71. Guo C.B., Wang S., Deng C., Zhang D.L., Wang F.L., and Jin X.Q. Relationship between matrix metalloproteinase 2 and lung cancer progression. Mol Diagn Ther 11 (2007) 183-192
72. Guo W., and Giancotti F.G. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5 (2004) 816-826
73. Gustafsson M.V., Zheng X., Pereira T., Gradin K., Jin S., Lundkvist J., et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9 (2005) 617-628
74. Halliwell B. Oxidative stress and cancer: have we moved forward?. Biochem J 401 (2007) 1-11
75. Hedley B.D., Welch D.R., Allan A.L., Al-Katib W., Dales D.W., Postenka C.O., et al. Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1. Int J Cancer 123 (2008) 526-534
76. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., and Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56 (1996) 4509-4515
77. Huang S., Van Arsdall M., Tedjarati S., McCarty M., Wu W., Langley R., et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94 (2002) 1134-1142
78. Hulleman E., and Boonstra J. Regulation of G1 phase progression by growth factors and the extracellular matrix. Cell Mol Life Sci 58 (2001) 80-93
79. Hunter K., Welch D.R., and Liu E.T. Genetic background is an important determinant of metastatic potential. Nat Genet 34 (2003) 23-24 [author reply 25]
80. Hur E., Kim H.H., Choi S.M., Kim J.H., Yim S., Kwon H.J., et al. Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1alpha/aryl hydrocarbon receptor nuclear translocator DNA binding by the 90-kDa heat-shock protein inhibitor radicicol. Mol Pharmacol 62 (2002) 975-982
81. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
82. Ingram J.L., and Bonner J.C. EGF and PDGF receptor tyrosine kinases as therapeutic targets for chronic lung diseases. Curr Mol Med 6 (2006) 409-421
83. Ishida T., Ishii T., Inagaki A., Yano H., Kusumoto S., Ri M., et al. The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma. Leukemia 20 (2006) 2162-2168
84. Iwasaki T., Higashiyama M., Kuriyama K., Sasaki A., Mukai M., Shinkai K., et al. NG-nitro-l-arginine methyl ester inhibits bone metastasis after modified intracardiac injection of human breast cancer cells in a nude mouse model. Jpn J Cancer Res 88 (1997) 861-866
85. Jang A., and Hill R.P. An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clin Exp Metastasis 15 (1997) 469-483
86. Jentsch T.J., Stein V., Weinreich F., and Zdebik A.A. Molecular structure and physiological function of chloride channels. Physiol Rev 82 (2002) 503-568
87. Juliano R.L., and Varner J.A. Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol 5 (1993) 812-818
88. Kabbinavar F.F., Schulz J., McCleod M., Patel T., Hamm J.T., Hecht J.R., et al. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 23 (2005) 3697-3705
89. Kaifi J.T., Yekebas E.F., Schurr P., Obonyo D., Wachowiak R., Busch P., et al. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer. J Natl Cancer Inst 97 (2005) 1840-1847
90. Kalluri R., and Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112 (2003) 1776-1784
91. Kalluri R., and Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 6 (2006) 392-401
92. Kapitsinou P.P., and Haase V.H. The VHL tumor suppressor and HIF: insights from genetic studies in mice. Cell Death Differ 15 (2008) 650-659
93. Kaplan R.N., Psaila B., and Lyden D. Bone marrow cells in the 'pre-metastatic niche': within bone and beyond. Cancer Metastasis Rev 25 (2006) 521-529
94. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
95. Karpatkin S., Pearlstein E., Ambrogio C., and Coller B.S. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest 81 (1988) 1012-1019
96. Kawanishi K., Shiozaki H., Doki Y., Sakita I., Inoue M., Yano M., et al. Prognostic significance of heat shock proteins 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer 85 (1999) 1649-1657
97. Keith B., and Simon M.C. Hypoxia-inducible factors, stem cells, and cancer. Cell 129 (2007) 465-472
98. Kenny H.A., Kaur S., Coussens L.M., and Lengyel E. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 118 (2008) 1367-1379
99. Khanna C., Wan X., Bose S., Cassaday R., Olomu O., Mendoza A., et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10 (2004) 182-186
100. Khazaie K., and von Boehmer H. The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer. Semin Cancer Biol 16 (2006) 124-136
101. Kim K.W., Bae S.K., Lee O.H., Bae M.H., Lee M.J., and Park B.C. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res 58 (1998) 348-351
102. Kimura H., Weisz A., Kurashima Y., Hashimoto K., Ogura T., D'Acquisto F., et al. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95 (2000) 189-197
103. King K.L., Li A.F., Chau G.Y., Chi C.W., Wu C.W., Huang C.L., et al. Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer 88 (2000) 2464-2470
104. Kitadai Y., Sasaki T., Kuwai T., Nakamura T., Bucana C.D., and Fidler I.J. Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma. Am J Pathol 169 (2006) 2054-2065
105. Kitadai Y., Sasaki T., Kuwai T., Nakamura T., Bucana C.D., Hamilton S.R., et al. Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential. Int J Cancer 119 (2006) 2567-2574
106. Knowles H.J., and Harris A.L. Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis. Breast Cancer Res 3 (2001) 318-322
107. Kovacs M.S., Hocking D.J., Evans J.W., Siim B.G., Wouters B.G., and Brown J.M. Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin. Br J Cancer 80 (1999) 1245-1251
108. Krishnamurthy P., Ross D.D., Nakanishi T., Bailey-Dell K., Zhou S., Mercer K.E., et al. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 279 (2004) 24218-24225
109. Kurschat P., and Mauch C. Mechanisms of metastasis. Clin Exp Dermatol 25 (2000) 482-489
110. Lafky J.M., Wilken J.A., Baron A.T., and Maihle N.J. Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochim Biophys Acta 1785 (2008) 232-265
111. Langley R.R., and Fidler I.J. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 28 (2007) 297-321
112. LeMaistre C.F., Meneghetti C., Howes L., and Osborne C.K. Targeting the EGF receptor in breast cancer treatment. Breast Cancer Res Treat 32 (1994) 97-103
113. Letsch A., Keilholz U., Schadendorf D., Assfalg G., Asemissen A.M., Thiel E., et al. Functional CCR9 expression is associated with small intestinal metastasis. J Invest Dermatol 122 (2004) 685-690
114. Levy L., and Hill C.S. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 17 (2006) 41-58
115. Li F., Tiede B., Massague J., and Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 17 (2007) 3-14
116. Liapis H., Flath A., and Kitazawa S. Integrin alpha V beta 3 expression by bone-residing breast cancer metastases. Diagn Mol Pathol 5 (1996) 127-135
117. Lievre A., Milet J., Carayol J., Le Corre D., Milan C., Pariente A., et al. Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma. BMC Cancer 6 (2006) 270
118. Lin E.Y., Gouon-Evans V., Nguyen A.V., and Pollard J.W. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 7 (2002) 147-162
119. Lin E.Y., Nguyen A.V., Russell R.G., and Pollard J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193 (2001) 727-740
120. Liotta L.A., and Kohn E.C. The microenvironment of the tumour-host interface. Nature 411 (2001) 375-379
121. Lobo N.A., Shimono Y., Qian D., and Clarke M.F. The biology of cancer stem cells. Annu Rev Cell Dev Biol 23 (2007) 675-699
122. Luker K.E., and Luker G.D. Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 238 (2006) 30-41
123. Luo S., Mao C., Lee B., and Lee A.S. GRP78/BiP is required for cell proliferation and protecting the inner cell mass from apoptosis during early mouse embryonic development. Mol Cell Biol 26 (2006) 5688-5697
124. Ma A., Koka R., and Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 24 (2006) 657-679
125. Maihle N.J., Baron A.T., Barrette B.A., Boardman C.H., Christensen T.A., Cora E.M., et al. EGF/ErbB receptor family in ovarian cancer. Cancer Treat Res 107 (2002) 247-258
126. Marcet-Palacios M., Graham K., Cass C., Befus A.D., Mayers I., and Radomski M.W. Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle. J Pharmacol Exp Ther 307 (2003) 429-436
127. Martin M., Pujuguet P., and Martin F. Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Pathol Res Pract 192 (1996) 712-717
128. Martin M.D., Carter K.J., Jean-Philippe S.R., Chang M., Mobashery S., Thiolloy S., et al. Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. Cancer Res 68 (2008) 6251-6259
129. Maruya S.I., Myers J.N., Weber R.S., Rosenthal D.I., Lotan R., and El-Naggar A.K. ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion!. Oral Oncol 41 (2005) 580-588
130. Mashino K., Sadanaga N., Yamaguchi H., Tanaka F., Ohta M., Shibuta K., et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 62 (2002) 2937-2941
131. Maulik N., and Das D.K. Redox signaling in vascular angiogenesis. Free Radic Biol Med 33 (2002) 1047-1060
132. Max R., Gerritsen R.R., Nooijen P.T., Goodman S.L., Sutter A., Keilholz U., et al. Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas. Int J Cancer 71 (1997) 320-324
133. McQuillan L.P., Leung G.K., Marsden P.A., Kostyk S.K., and Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol 267 (1994) H1921-H1927
134. Medina R.A., and Owen G.I. Glucose transporters: expression, regulation and cancer. Biol Res 35 (2002) 9-26
135. Mehlen P., and Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 6 (2006) 449-458
136. Melillo G., Musso T., Sica A., Taylor L.S., Cox G.W., and Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182 (1995) 1683-1693
137. Mendes O., Kim H.T., and Stoica G. Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin Exp Metastasis 22 (2005) 237-246
138. Minchenko A., Salceda S., Bauer T., and Caro J. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res 40 (1994) 35-39
139. Monti S., Proietti-Pannunzi L., Sciarra A., Lolli F., Falasca P., Poggi M., et al. The IGF axis in prostate cancer. Curr Pharm Des 13 (2007) 719-727
140. Mueller M.M., and Fusenig N.E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4 (2004) 839-849
141. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
142. Murakami T., Cardones A.R., Finkelstein S.E., Restifo N.P., Klaunberg B.A., Nestle F.O., et al. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 198 (2003) 1337-1347
143. Murakami T., Maki W., Cardones A.R., Fang H., Tun Kyi A., Nestle F.O., et al. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 62 (2002) 7328-7334
144. Nakamura Y., Yasuoka H., Tsujimoto M., Yoshidome K., Nakahara M., Nakao K., et al. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis. Clin Cancer Res 12 (2006) 1201-1207
145. Natali P., Nicotra M.R., Cavaliere R., Bigotti A., Romano G., Temponi M., et al. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res 50 (1990) 1271-1278
146. Natali P.G., Hamby C.V., Felding-Habermann B., Liang B., Nicotra M.R., Di Filippo F., et al. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res 57 (1997) 1554-1560
147. Naylor M.J., Li N., Cheung J., Lowe E.T., Lambert E., Marlow R., et al. Ablation of beta1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation. J Cell Biol 171 (2005) 717-728
148. Negus R.P., Stamp G.W., Hadley J., and Balkwill F.R. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 150 (1997) 1723-1734
149. Nicola M.H., Bizon R., Machado J.J., Sollero T., Rodarte R.S., Nobre J.S., et al. Breast cancer micrometastases: different interactions of carcinoma cells with normal and cancer patients' bone marrow stromata. Clin Exp Metastasis 20 (2003) 471-479
150. Nikolopoulos S.N., Blaikie P., Yoshioka T., Guo W., and Giancotti F.G. Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell 6 (2004) 471-483
151. Nip J., Shibata H., Loskutoff D.J., Cheresh D.A., and Brodt P. Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin. J Clin Invest 90 (1992) 1406-1413
152. Nishi H., Nakada T., Kyo S., Inoue M., Shay J.W., and Isaka K. Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol Cell Biol 24 (2004) 6076-6083
153. Notohamiprodjo M., Segerer S., Huss R., Hildebrandt B., Soler D., Djafarzadeh R., et al. CCR10 is expressed in cutaneous T-cell lymphoma. Int J Cancer 115 (2005) 641-647
154. Nowicki A., Szenajch J., Ostrowska G., Wojtowicz A., Wojtowicz K., Kruszewski A.A., et al. Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. Int J Cancer 65 (1996) 112-119
155. Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., and Cunha G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59 (1999) 5002-5011
156. Ozturk M.A., Guven G.S., and Haznedaroglu I.C. How hematopoietic stem cells know and act in cardiac microenvironment for stem cell plasticity? Impact of local renin-angiotensin systems. Med Hypotheses 63 (2004) 866-874
157. Paule B. Potential therapeutic implications of EGF R/PDGF R signalling pathways in bone metastases of prostate cancer. Prog Urol 15 (2005) 616-620
158. Pawelec G. Tumour escape: antitumour effectors too much of a good thing?. Cancer Immunol Immunother 53 (2004) 262-274
159. Pipili-Synetos E., Papageorgiou A., Sakkoula E., Sotiropoulou G., Fotsis T., Karakiulakis G., et al. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol 116 (1995) 1829-1834
160. Podsypanina K., Du Y.C., Jechlinger M., Beverly L.J., Hambardzumyan D., and Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 321 (2008) 1841-1844
161. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4 (2004) 71-78
162. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 104 (2007) 973-978
163. Pyrko P., Schonthal A.H., Hofman F.M., Chen T.C., and Lee A.S. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res 67 (2007) 9809-9816
164. Radisky D.C., Levy D.D., Littlepage L.E., Liu H., Nelson C.M., Fata J.E., et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436 (2005) 123-127
165. Radomski M.W., Jenkins D.C., Holmes L., and Moncada S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 51 (1991) 6073-6078
166. Ramirez-Castillejo C., Sanchez-Sanchez F., Andreu-Agullo C., Ferron S.R., Aroca-Aguilar J.D., Sanchez P., et al. Pigment epithelium-derived factor is a niche signal for neural stem cell renewal. Nat Neurosci 9 (2006) 331-339
167. Ramsay A.G., Marshall J.F., and Hart I.R. Integrin trafficking and its role in cancer metastasis. Cancer Metastasis Rev 26 (2007) 567-578
168. Ranganathan A.C., Zhang L., Adam A.P., and Aguirre-Ghiso J.A. Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res 66 (2006) 1702-1711
169. Reddig P.J., and Juliano R.L. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev 24 (2005) 425-439
170. Reichert T.E., Strauss L., Wagner E.M., Gooding W., and Whiteside T.L. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Clin Cancer Res 8 (2002) 3137-3145
171. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
172. Reynolds T.Y., Rockwell S., and Glazer P.M. Genetic instability induced by the tumor microenvironment. Cancer Res 56 (1996) 5754-5757
173. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007) 111-115
174. Rofstad E.K., and Danielsen T. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis. Br J Cancer 80 (1999) 1697-1707
175. Rofstad E.K., Sundfor K., Lyng H., and Trope C.G. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br J Cancer 83 (2000) 354-359
176. Rogers S., Docherty S.E., Slavin J.L., Henderson M.A., and Best J.D. Differential expression of GLUT12 in breast cancer and normal breast tissue. Cancer Lett 193 (2003) 225-233
177. Roland C.L., Harken A.H., Sarr M.G., and Barnett Jr. C.C. ICAM-1 expression determines malignant potential of cancer. Surgery 141 (2007) 705-707
178. Rong S., and Vande Woude G.F. Autocrine mechanism for met proto-oncogene tumorigenicity. Cold Spring Harb Symp Quant Biol 59 (1994) 629-636
179. Ronnov-Jessen L., Petersen O.W., Koteliansky V.E., and Bissell M.J. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted
180. Rook A.H., Kehrl J.H., Wakefield L.M., Roberts A.B., Sporn M.B., Burlington D.B., et al. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136 (1986) 3916-3920
181. Rosette C., Roth R.B., Oeth P., Braun A., Kammerer S., Ekblom J., et al. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 26 (2005) 943-950
182. Roussidis A.E., Theocharis A.D., Tzanakakis G.N., and Karamanos N.K. The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer. Curr Med Chem 14 (2007) 735-743
183. Saldivar, JS, Chen Z, Sommer S. EGF receptor testing for non-small cell lung carcinomas. Curr Protoc Hum Genet 2006;Chapter 10,Unit 10 9.
184. Samani A.A., Yakar S., LeRoith D., and Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28 (2007) 20-47
185. Sandau K.B., Zhou J., Kietzmann T., and Brune B. Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. J Biol Chem 276 (2001) 39805-39811
186. Sandler A., Gray R., Perry M.C., Brahmer J., Schiller J.H., Dowlati A., et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355 (2006) 2542-2550
187. Scadden D.T. The stem-cell niche as an entity of action. Nature 441 (2006) 1075-1079
188. Scheel C., Onder T., Karnoub A., and Weinberg R.A. Adaptation versus selection: the origins of metastatic behavior. Cancer Res 67 (2007) 11476-11479 [discussion 11479-80]
189. Seemayer T.A., Lagace R., Schurch W., and Tremblay G. Myofibroblasts in the stroma of invasive and metastatic carcinoma: a possible host response to neoplasia. Am J Surg Pathol 3 (1979) 525-533
190. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3 (2003) 721-732
191. Semenza G.L., and Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12 (1992) 5447-5454
192. Shen Q., Goderie S.K., Jin L., Karanth N., Sun Y., Abramova N., et al. Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304 (2004) 1338-1340
193. Shweiki D., Itin A., Soffer D., and Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359 (1992) 843-845
194. Singh S., Singh U.P., Stiles J.K., Grizzle W.E., and Lillard Jr. J.W. Expression and functional role of CCR9 in prostate cancer cell migration and invasion. Clin Cancer Res 10 (2004) 8743-8750
195. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., et al. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
196. Sisci D., and Surmacz E. Crosstalk between IGF signaling and steroid hormone receptors in breast cancer. Curr Pharm Des 13 (2007) 705-717
197. Smith T.A. Facilitative glucose transporter expression in human cancer tissue. Br J Biomed Sci 56 (1999) 285-292
198. Smits A., and Funa K. Platelet-derived growth factor (PDGF) in primary brain tumours of neuroglial origin. Histol Histopathol 13 (1998) 511-520
199. Sokolowska-Wojdylo M., Wenzel J., Gaffal E., Lenz J., Speuser P., Erdmann S., et al. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol 152 (2005) 258-264
200. Steeg P.S., and Theodorescu D. Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol 5 (2008) 206-219
201. Sternlicht M.D., Lochter A., Sympson C.J., Huey B., Rougier J.P., Gray J.W., et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98 (1999) 137-146
202. Stetler-Stevenson W.G., Aznavoorian S., and Liotta L.A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9 (1993) 541-573
203. Suh K.S., Crutchley J.M., Koochek A., Ryscavage A., Bhat K., Tanaka T., et al. Reciprocal modifications of CLIC4 in tumor epithelium and stroma mark malignant progression of multiple human cancers. Clin Cancer Res 13 (2007) 121-131
204. Suh K.S., Mutoh M., Gerdes M., Crutchley J.M., Mutoh T., Edwards L.E., et al. Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor {alpha}-induced apoptosis, and inhibits tumor growth. Cancer Res 65 (2005) 562-571
205. Suh K.S., Mutoh M., Nagashima K., Fernandez-Salas E., Edwards L.E., Hayes D.D., et al. The organellular chloride channel protein CLIC4/mtCLIC translocates to the nucleus in response to cellular stress and accelerates apoptosis. J Biol Chem 279 (2004) 4632-4641
206. Sun J.J., Zhou X.D., Zhou G., and Liu Y.K. Expression of intercellular adhesive molecule-1 in liver cancer tissues andliver cancer metastasis. World J Gastroenterol 4 (1998) 202-205
207. Syrigos K.N., Harrington K.J., Karayiannakis A.J., Sekara E., Chatziyianni E., Syrigou E.I., et al. Clinical significance of heat shock protein-70 expression in bladder cancer. Urology 61 (2003) 677-680
208. Tachimori A., Yamada N., Sakate Y., Yashiro M., Maeda K., Ohira M., et al. Up regulation of ICAM-1 gene expression inhibits tumour growth and liver metastasis in colorectal carcinoma. Eur J Cancer 41 (2005) 1802-1810
209. Takanami I. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer 105 (2003) 186-189
210. Takeuchi H., Fujimoto A., Tanaka M., Yamano T., Hsueh E., and Hoon D.S. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 10 (2004) 2351-2358
211. Talmadge J.E. Clonal selection of metastasis within the life history of a tumor. Cancer Res 67 (2007) 11471-11475
212. Tanaka H., Yashiro M., Sunami T., Sakate Y., Kosaka K., and Hirakawa K. ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma. Clin Cancer Res 10 (2004) 4885-4892
213. Teicher B.A. Transforming growth factor-beta and the immune response to malignant disease. Clin Cancer Res 13 (2007) 6247-6251
214. Thanner F., Sutterlin M.W., Kapp M., Rieger L., Kristen P., Dietl J., et al. Heat-shock protein 70 as a prognostic marker in node-negative breast cancer. Anticancer Res 23 (2003) 1057-1062
215. Till K.J., Lin K., Zuzel M., and Cawley J.C. The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood 99 (2002) 2977-2984
216. Tlsty T.D. Stromal cells can contribute oncogenic signals. Semin Cancer Biol 11 (2001) 97-104
217. Toker A., and Yoeli-Lerner M. Akt signaling and cancer: surviving but not moving on. Cancer Res 66 (2006) 3963-3966
218. Tomasovic S.P., Rosenblatt P.L., Johnston D.A., Tang K., and Lee P.S. Heterogeneity in induced heat resistance and its relation to synthesis of stress proteins in rat tumor cell clones. Cancer Res 44 (1984) 5850-5856
219. Uozaki H., Ishida T., Kakiuchi C., Horiuchi H., Gotoh T., Iijima T., et al. Expression of heat shock proteins in osteosarcoma and its relationship to prognosis. Pathol Res Pract 196 (2000) 665-673
220. Ura H., Denno R., Hirata K., Yamaguchi K., and Yasoshima T. Separate functions of alpha2beta1 and alpha3beta1 integrins in the metastatic process of human gastric carcinoma. Surg Today 28 (1998) 1001-1006
221. Vermeulen L., Sprick M.R., Kemper K., Stassi G., and Medema J.P. Cancer stem cells-old concepts, new insights. Cell Death Differ 15 (2008) 947-958
222. Wahl S.M., Wen J., and Moutsopoulos N. TGF-beta: a mobile purveyor of immune privilege. Immunol Rev 213 (2006) 213-227
223. Wang B., Xiong Q., Shi Q., Le X., Abbruzzese J.L., and Xie K. Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma. Cancer Res 61 (2001) 71-75
224. Warburg O. Origin of cancer cells. Oncologia 9 (1956) 75-83
225. Weiss L., Orr F.W., and Honn K.V. Interactions of cancer cells with the microvasculature during metastasis. FASEB J 2 (1988) 12-21
226. Welch D.R., Schissel D.J., Howrey R.P., and Aeed P.A. Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc Natl Acad Sci U S A 86 (1989) 5859-5863
227. Wicha M.S., Liu S., and Dontu G. Cancer stem cells: an old idea-a paradigm shift. Cancer Res 66 (2006) 1883-1890 [discussion 1895-6]
228. Wiley H.E., Gonzalez E.B., Maki W., Wu M.T., and Hwang S.T. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93 (2001) 1638-1643
229. Witz I.P., and Levy-Nissenbaum O. The tumor microenvironment in the post-PAGET era. Cancer Lett 242 (2006) 1-10
230. Wu L.M., Zhang F., Xie H.Y., Xu X., Chen Q.X., Yin S.Y., et al. MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation. Clin Genet 73 (2008) 273-278
231. Xie K., and Fidler I.J. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev 17 (1998) 55-75
232. Xie K., and Huang S. Regulation of cancer metastasis by stress pathways. Clin Exp Metastasis 20 (2003) 31-43
233. Xu W., Mimnaugh E., Rosser M.F., Nicchitta C., Marcu M., Yarden Y., et al. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. J Biol Chem 276 (2001) 3702-3708
234. Yamaguchi H., Pixley F., and Condeelis J. Invadopodia and podosomes in tumor invasion. Eur J Cell Biol 85 (2006) 213-218
235. Yamamoto T., Terada N., Nishizawa Y., Tanaka H., Akedo H., Seiyama A., et al. Effects of NG-nitro-l-arginine and/or l-arginine on experimental pulmonary metastasis in mice. Cancer Lett 87 (1994) 115-120
236. Yamamoto T., Terada N., Seiyama A., Nishizawa Y., Akedo H., and Kosaka H. Increase in experimental pulmonary metastasis in mice by l-arginine under inhibition of nitric oxide production by NG-nitro-l-arginine methyl ester. Int J Cancer 75 (1998) 140-144
237. Yang L., and Carbone D.P. Tumor-host immune interactions and dendritic cell dysfunction. Adv Cancer Res 92 (2004) 13-27
238. Yang Z.J., and Wechsler-Reya R.J. Hit'em where they live: targeting the cancer stem cell niche. Cancer Cell 11 (2007) 3-5
239. Yin J.J., Mohammad K.S., Kakonen S.M., Harris S., Wu-Wong J.R., Wessale J.L., et al. A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. Proc Natl Acad Sci U S A 100 (2003) 10954-10959
240. Younes M., Lechago L.V., Somoano J.R., Mosharaf M., and Lechago J. Immunohistochemical detection of Glut3 in human tumors and normal tissues. Anticancer Res 17 (1997) 2747-2750
241. Young S.D., Marshall R.S., and Hill R.P. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A 85 (1988) 9533-9537
242. Yu Y., Khan J., Khanna C., Helman L., Meltzer P.S., and Merlino G. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 10 (2004) 175-181
243. Zeisberg M., Strutz F., and Muller G.A. Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol 13 Suppl. 3 (2000) S111-120
244. Zhang H., and Burrows F. Targeting multiple signal transduction pathways through inhibition of Hsp90. J Mol Med 82 (2004) 488-499
245. Zhang J., Jiang Y., Jia Z., Li Q., Gong W., Wang L., et al. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin Exp Metastasis 23 (2006) 401-410
246. Zhao L., Liu L., Wang S., Zhang Y.F., Yu L., and Ding Y.Q. Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins. J Cancer Res Clin Oncol 133 (2007) 771-782